

Nab Paclitor™
Generic Name
Nanoparticle albumin-bound paclitaxel Inj. (Nab-Paclitaxel Inj.)
Therapeutic Class
Oncology
Storage Conditions: Store reconstituted suspension in the original carton at 2 °C to 8 °C to protect from light. Use reconstituted suspension within 24 hours. Do not store above 25 °C temperature. Keep away from light and wet place. Keep out of reach of children.
FDA Approved Indications:
Nab Paclitor™ is a microtubule inhibitor indicated for the treatment of:
• Metastatic breast cancer, after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy. Prior therapy should have included an anthracycline unless clinically contraindicated.
• Locally advanced or metastatic non-small cell lung cancer (NSCLC), as first-line treatment in combination with carboplatin, in patients who are not candidates for curative surgery or radiation therapy.
• Metastatic adenocarcinoma of the pancreas as first-line treatment, in combination with Gemcitabine.